InflaRx IFRX
NASDAQ IFRX
$1.54 +0.09 (+6.21%)
At close: Oct 20, 2026 · 4:00 PM EDT

InflaRx (IFRX) Receivables (2024 - 2025)

Updated

InflaRx (IFRX) posted Receivables of $3.74 million for Q2 2025, down 100.0% from $25.55 billion a year earlier.

Analysis

InflaRx (IFRX) Receivables (2024 - 2025) Analysis & Trends

At the end of FY2024, InflaRx's Receivables came in at $1.92 million.

  • Quarterly Receivables has run from a low of $38,286 in Q1 2024 to a high of $25.55 billion in Q2 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 19.05 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 13.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 12.49 Bn
10 InflaRx 105.98 Mn -227.64 Mn 2.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.87 Mn
Dec 31, 2024 1.87 Mn
Sep 30, 2024 97,815.19
Jun 30, 2024 25,407.99
Mar 31, 2024 38,041.88
API Access

InflaRx Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=IFRX&period=max&api_key=YOUR_API_KEY